1-20 of 20
Keri Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Number Needed to Treat Analyses of Zanubrutinib in Relapsed/Refractory Chronic Lymphocytic Leukaemia

Asher Alban Chanan-Khan, Kirollos S. Hanna, Mei Xue, Marjan Massoudi, Mark Balk, Hossein ZivariPiran, Cecilia Duan, Keri Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2337.
https://doi.org/10.1182/blood-2023-174709
Published: 2023
Journal Articles

Recent Patterns of Care with BTK Inhibitors and Distribution of Social Determinants of Health Among Patients with CLL/SLL in the US Community Setting

David J Andorsky, Ira Zackon, Thomas W Wilson, Kathleen M Aguilar, Chuck Wentworth, Yunfei Wang, Scott Goldfarb, Keri Yang, Erlene Kuizon Seymour, Mark Balk, Gregory A Maglinte
Journal: Blood
Blood (2023) 142 (Supplement 1): 2413.
https://doi.org/10.1182/blood-2023-172880
Published: 2023
Journal Articles

Toxicity, Progression-Free Survival, and Quality of Life of Patients Treated with Zanubrutinib Versus Ibrutinib: A Q-TWiST Analysis from the ALPINE Study in Relapsed or Refractory Chronic Lymphocytic Leukemia

Vincent Levy, Tushar Srivastava, Keri Yang, Palash Purkayastha, Raju Gautam, Kaijun Wang, Leyla Mohseninejad
Journal: Blood
Blood (2023) 142 (Supplement 1): 1909.
https://doi.org/10.1182/blood-2023-173540
Published: 2023
Journal Articles

Impact of Real-World Treatment Sequencing Patterns on Time to Next Treatment among Patients with Chronic Lymphocytic Leukemia in the United States

Asher Alban Chanan-Khan, Swetha Challagulla, Alpana Kaushiva, Vincent Miller, Yuexi Wang, Helen Smith, Keri Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5143.
https://doi.org/10.1182/blood-2023-179536
Published: 2023
Journal Articles

Real-World Evaluation of Treatment Discontinuation and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Asher Alban Chanan-Khan, Swetha Challagulla, Elizabeth Donckels, Po-Ya Chuang, Keri Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5144.
https://doi.org/10.1182/blood-2023-179948
Published: 2023
Journal Articles

Real-World Switching Pattern, Persistence, and Associated Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States

Bijal D. Shah, Mei Xue, Wesley Furnback, Kaitlyn Esselman, Po-Ya Chuang, Keri Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5155.
https://doi.org/10.1182/blood-2023-178787
Published: 2023
Journal Articles

Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Mazyar Shadman, Alessandra Tedeschi, Leyla Mohseninejad, Keri Yang, Nicole Lamanna, Sheng Xu, Aileen Cleary Cohen, Swetha Challagulla, Mei Xue, Rhys Williams, Susan M. O'Brien, Jennifer R. Brown, Constantine S. Tam
Journal: Blood
Blood (2023) 142 (Supplement 1): 4655.
https://doi.org/10.1182/blood-2023-179222
Published: 2023
Journal Articles

Zanubrutinib vs FCR in Fit Treatment-Naive Patients with Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Talha Munir, Leyla Mohseninejad, Sheng Xu, Milica Jevdjevic, Walter Bouwmeester, Keri Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6522.
https://doi.org/10.1182/blood-2023-173172
Published: 2023
Journal Articles

Real-World Patterns of Care and Financial Burden of Patients with Follicular Lymphoma in the United States

Bijal D. Shah, Mei Xue, Erlene Kuizon Seymour, Wesley Furnback, Po-Ya Chuang, Keri Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5137.
https://doi.org/10.1182/blood-2023-179556
Published: 2023
Journal Articles

Real-World Evidence on Shift in Treatment Practice and Adoption of Novel Agents for Patients with Chronic Lymphocytic Leukemia in the United States

Asher Chanan-Khan, Keri Yang, Sizhu Liu, Todd Zimmerman, Boxiong Tang, Sikander Ailawadhi
Journal: Blood
Blood (2021) 138 (Supplement 1): 5013.
https://doi.org/10.1182/blood-2021-148736
Published: 2021
Journal Articles

Productivity Loss and Indirect Costs Among Non-Hodgkin Lymphoma Patients and Their Caregivers

Keri Yang, Sizhu Liu, Debra Irwin, Elizabeth Packnett, Carolyn R. Lew, Virginia Noxon, Boxiong Tang, Asher Chanan-Khan
Journal: Blood
Blood (2021) 138 (Supplement 1): 4009.
https://doi.org/10.1182/blood-2021-148443
Published: 2021
Journal Articles

Factors Associated with Treatment Among Older Adults Diagnosed with Chronic Lymphocytic Leukemia: An Analysis Using Medicare Claims Data

Eberechukwu Onukwugha, Tsung-Ying Lee, Johnson Abree, Catherine Cooke, Summers Amanda, Keri Yang, Sizhu Liu, Boxiong Tang, Yared Jean
Journal: Blood
Blood (2021) 138 (Supplement 1): 1968.
https://doi.org/10.1182/blood-2021-148727
Published: 2021
Journal Articles

Real-World Treatment Patterns, Adherence and Healthcare Resource Utilization for Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia Among Veterans in the United States

Keri Yang, Sizhu Liu, Boxiong Tang, Asher Chanan-Khan
Journal: Blood
Blood (2021) 138 (Supplement 1): 4079.
https://doi.org/10.1182/blood-2021-148716
Published: 2021
Journal Articles

Real-World Testing Patterns for Risk Assessment and Implications on the Adoption of Novel Therapeutics in Chronic Lymphocytic Leukemia: IGHV Mutation Status, FISH Cytogenetic, and Immunophenotyping

Asher Chanan-Khan, Keri Yang, Tom Liu, Todd Zimmerman, Boxiong Tang, Sikander Ailawadhi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4078.
https://doi.org/10.1182/blood-2021-147955
Published: 2021
Journal Articles

Impact of Atrial Fibrillation on Cardiovascular and Economic Outcomes in Patients with Chronic Lymphocytic Leukemia

Anjana Mohan, Keri Yang, Sizhu Liu, Randall Dick, Boxiong Tang, Asher Chanan-Khan
Journal: Blood
Blood (2021) 138 (Supplement 1): 4077.
https://doi.org/10.1182/blood-2021-148600
Published: 2021
Journal Articles

Real-World Bruton Tyrosine Kinase Inhibitor Treatment Patterns, Compliance, Costs, and Hospitalizations in Patients with Mantle Cell Lymphoma in the United States

Bijal D. Shah, Keri Yang, Sizhu Liu, Jai Sivanantham, Yasser Ali, Chris Casten, Swaroop Satya, Boxiong Tang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3046.
https://doi.org/10.1182/blood-2021-148053
Published: 2021
Journal Articles

Real-World Disease Burden, Costs and Resource Utilization of Hospital-Based Care Among Mantle Cell Lymphoma, Waldenström Macroglobulinemia, Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia: Disparities and Risk Factors

Asher Chanan-Khan, Keri Yang, Sizhu Liu, Zhun Cao, Dorothy Baumer, Shanthi Krishnaswami, Boxiong Tang, Sikander Ailawadhi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3048.
https://doi.org/10.1182/blood-2021-148633
Published: 2021
Journal Articles

A Clinical Practice Comparison of Overall Survival, Time-to-Next-Treatment, and Time-to-Treatment-Discontinuation Among CLL/SLL Patients Receiving First-Line Ibrutinib with and without a Del(17p) Mutation

Anthony Mato, MD, Boxiong Tang, MD PhD, Soraya Azmi, MBBS,MPH, Keri Yang, PhD MPH, MS, Jennifer C Stern, PhD, Eric Hedrick, MD, Jane Huang, MD, Jeff P Sharman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-134119
Published: 2020
Journal Articles

A Systematic Review of the Epidemiology and Economic Burden of Mantle Cell Lymphoma (MCL)

Keri Keri Yang, Eleanor Lucas, BA, Beth Lesher, PharmD, Tony Caver, PhD, Boxiong Tang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5831.
https://doi.org/10.1182/blood-2019-129677
Published: 2019
Journal Articles

Systematic Literature Review on Global Real-World Treatment Patterns of Mantle Cell Lymphoma (MCL)

Keri Keri Yang, Beth Lesher, PharmD, Eleanor Lucas, BA, Tony Caver, PhD, Boxiong Tang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5881.
https://doi.org/10.1182/blood-2019-130896
Published: 2019